Skip to main content


Aims and scope

Molecular Neurodegeneration (MN) is an open access, peer-reviewed journal dedicated to publishing groundbreaking research in the field of neurodegeneration. Our mission is to foster a deeper understanding of neurodegenerative diseases, including but not limited to Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, glaucoma, and macular degeneration, to inform novel diagnosis and effective therapy. We aim to publish innovative studies addressing the complex mechanisms of neurodegenerative disorders at the molecular, cellular, and systems levels, with a strong emphasis on broad impact and scientific rigor.

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    15.1 - 2-year Impact Factor
    15.8 - 5-year Impact Factor
    3.022 - SNIP (Source Normalized Impact per Paper)
    5.158 - SJR (SCImago Journal Rank)

    2023 Speed
    30 days submission to first editorial decision for all manuscripts (Average)
    143 days submission to accept (Average)

    2023 Usage 
    2,567 Altmetric mentions

Contact the Managing Editorial Team

Hongmei Li 

Lucy Job 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline